The confirmation of H5N1 highly pathogenic avian influenza (HPAI) in New Zealand on July 15, 2026, has activated a coverage question that brokers and underwriters operating in this market have been quietly flagging for months: when a biosecurity event triggers the government’s cost-sharing framework, what losses fall through the gap – and who is holding them? The answer, based on how the market currently operates, is that the gap is structural, documented, and widening.
Biosecurity Minister Andrew Hoggard confirmed that a brown skua found on Petone beach in Wellington tested positive for H5N1 clade 2.3.4.4b – the globally circulating strain responsible for what the UN Food and Agriculture Organization (FAO) describes as massive losses in domestic bird populations, supply disruptions, and rising poultry prices across multiple regions over the past four years. There is no detection in commercial poultry. The Ministry for Primary Industries (MPI) confirmed checks along Petone beach found no additional affected birds. “This is a coastal detection in an individual ocean-going seabird, and there is no evidence of any mass mortality in wildlife or transmission between wild birds in New Zealand. There has been no detection in poultry,” Hoggard said.
New Zealand’s Government Industry Agreement (GIA) operational agreement, signed in August 2025 between the government, the Egg Producers Federation (EPF), and the Poultry Industry Association of New Zealand (PIANZ), sets the cost-sharing architecture for any H5N1 response. Industry will contribute 45% of readiness costs for all poultry diseases and 45% of response costs – except for H5N1 HPAI, for which the industry share is 40% of response costs, covering diagnostics, communications, and disease-control activities. Cost-shareable activities for an H5N1 outbreak have been agreed to be limited, and industry is expected to lead the on-farm response as soon as possible after detection, with MPI support.
Critically, what the GIA framework does not cover is the consequential loss. New Zealand’s most recent HPAI event illustrates the scale of that exposure precisely. In December 2024, HPAI H7N6 was confirmed at Mainland Poultry’s Hillgrove farm in Otago, triggering the culling of approximately 200,000 hens, movement controls lasting nearly five months, over 5,600 tests across 36 flocks at five linked farms, and disruption to approximately $300 million in poultry trade. The direct cost of that single-farm outbreak was estimated at $25 million, with the government approving $20 million in additional funding to cover unbudgeted MPI costs including testing, surveillance, and compensation. Movement controls imposed on uninfected linked farms produced revenue losses sitting entirely outside the GIA framework.
H5N1 carries a structurally more severe risk profile. Overseas experience indicates that if H5N1 arrives in New Zealand and becomes widespread in wild birds, eradication is unlikely. That single line from MPI’s own guidance reframes every financial model built around the H7N6 precedent.
Broker Lockton, operating in New Zealand, has published direct guidance on the structural limitation of the private market’s response. Bird flu cover is limited and not readily available in all regions given the severity of potential losses. Cover is often sub-limited to provide only a proportion of the full limit, and cover becomes severely restricted once an outbreak occurs. Lockton advises producers to secure protection before the virus reaches their region – advice that, as of July 15, 2026, carries immediate application for New Zealand clients.
The gap is not unique to New Zealand. Broker Howden, assessing the risk in the context of Australia’s H5N1 detection in June 2026, has argued that H5N1 clade 2.3.4.4b presents a different risk profile from earlier strains because it has become established in wild bird populations across multiple continents, spreading through migratory pathways and creating repeated spillover opportunities rather than isolated events. Howden also identifies egg supply as likely to be affected earlier than chicken meat, given flock-replacement timeframes, and flags downstream exposures across food manufacturing, retail logistics, and hospitality – sectors whose insurers may not have priced avian influenza into their business interruption books.
Insurance solutions can provide cover for livestock losses, clean-up, and business interruption costs, but following an outbreak, farmers may face reduced capacity and higher premiums. For New Zealand producers, that window has now opened.
Separate from the detection, a compliance shift already in progress will change the risk profile of operators across the sector. MPI has proposed regulations requiring commercial poultry operators to develop formal avian biosecurity control programmes, meet auditable biosecurity standards covering depopulation, disposal, cleaning and disinfection, maintain records, and bear partial cost recovery for audits – with fines for non-compliance. The regulations extend in part to semi-commercial and non-commercial poultry owners, including pet poultry, and MPI has acknowledged the costs may cause some operators to exit the industry.
In 2024, New Zealand poultry farms produced around 225,000 tonnes of meat equivalent to approximately 122 million birds, and the egg industry produced over 90 million dozen eggs. The sector generates an estimated $2.2 billion in annual domestic revenue and $200 million in export revenue. That is the exposure base sitting behind a private insurance market that its own participants describe as limited and tightening at precisely the moment the risk has become confirmed.
The Insurance Council of New Zealand (ICNZ) has not issued avian influenza-specific guidance to date. ICNZ’s 2025 annual review notes total insurance claims hit $3.8 billion and warns that “New Zealand faces growing and interconnected risks” – but its current public focus remains on climate and natural hazard resilience. Biosecurity risk, now confirmed in New Zealand’s wild bird population, represents a category the industry body has yet to address publicly. “We are continuing to act early and prepare carefully,” Hoggard said.
